|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 44.11 USD | -2.28% |
|
+4.43% | -25.38% |
| 11/06 | The Carlyle Group Inc. Presents at Morgan Stanley US Financials Conference 2026, Jun-10-2026 02:30 PM | |
| 10/06 | Carlyle Seeks Banks to Advise on India IPO of Healthcare RCM Business | MT |
Company Valuation: The Carlyle Group Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 19,570 | 10,850 | 14,681 | 18,059 | 21,304 | 15,878 | - | - |
| Change | - | -44.56% | 35.31% | 23.01% | 17.97% | -25.47% | - | - |
| Enterprise Value (EV) 1 | 24,852 | 17,379 | 21,660 | 24,970 | 21,304 | 15,565 | 14,161 | 15,878 |
| Change | - | -30.07% | 24.64% | 15.28% | -14.68% | -26.94% | -9.02% | 12.13% |
| P/E Ratio | - | 8.91x | -24.2x | 18.2x | 27.1x | 12.4x | 10.2x | 9.45x |
| PBR | 3.7x | 1.74x | 2.54x | 2.84x | - | 0.85x | 1.13x | 1.03x |
| PEG | - | - | 0x | -0x | -1.3x | 0.2x | 0.5x | 1.13x |
| Capitalization / Revenue | 3.95x | 2.47x | 4.31x | 4.94x | 5.46x | 4.19x | 3.15x | 2.84x |
| EV / Revenue | 5.02x | 3.95x | 6.36x | 6.83x | 5.46x | 4.11x | 2.81x | 2.84x |
| EV / EBITDA | 10.9x | 8.92x | 14.7x | 15.9x | 12.2x | 11.6x | 8.06x | 7.18x |
| EV / EBIT | 11.1x | 9.1x | 15.1x | 16.4x | 12.6x | 9.56x | 6.78x | 5.94x |
| EV / FCF | - | -41.4x | 157x | -29.8x | - | 10.1x | 7.13x | 8.39x |
| FCF Yield | - | -2.42% | 0.64% | -3.35% | - | 9.86% | 14% | 11.9% |
| Dividend per Share 2 | 1 | 1.3 | 1.4 | 1.4 | 1.4 | 1.4 | 1.464 | 1.623 |
| Rate of return | 1.82% | 4.36% | 3.44% | 2.77% | 2.37% | 3.17% | 3.32% | 3.68% |
| EPS 2 | - | 3.35 | -1.68 | 2.77 | 2.18 | 3.559 | 4.307 | 4.667 |
| Distribution rate | - | 38.8% | -83.3% | 50.5% | 64.2% | 39.3% | 34% | 34.8% |
| Net sales 1 | 4,950 | 4,401 | 3,405 | 3,655 | 3,902 | 3,791 | 5,043 | 5,598 |
| EBITDA 1 | 2,281 | 1,948 | 1,468 | 1,572 | 1,745 | 1,339 | 1,758 | 2,212 |
| EBIT 1 | 2,244 | 1,909 | 1,430 | 1,526 | 1,691 | 1,628 | 2,089 | 2,673 |
| Net income 1 | - | 1,225 | -608.4 | 1,020 | 808.7 | 1,603 | 1,840 | 1,915 |
| Net Debt 1 | 5,283 | 6,529 | 6,979 | 6,911 | - | -313.5 | -1,717 | - |
| Reference price 2 | 54.90 | 29.84 | 40.69 | 50.49 | 59.11 | 44.11 | 44.11 | 44.11 |
| Nbr of stocks (in thousands) | 3,56,462 | 3,63,605 | 3,60,796 | 3,57,681 | 3,60,410 | 3,59,974 | - | - |
| Announcement Date | 03/02/22 | 07/02/23 | 07/02/24 | 11/02/25 | 06/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E Ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 12.39x | 4.11x | 11.62x | 3.17% | 1.59TCr | ||
| 19.83x | 6.87x | 13.17x | 4.36% | 9.31TCr | ||
| 26.32x | 8.42x | 13.1x | 0.83% | 8.53TCr | ||
| 21.43x | 6.19x | 14.32x | 4.22% | 2.89TCr | ||
| 11.16x | 4.34x | 8.61x | 5.77% | 1.9TCr | ||
| 18.11x | 1.77x | 6.73x | 4.22% | 1.62TCr | ||
| 12.21x | 9.29x | - | 10.08% | 1.37TCr | ||
| 33.04x | 18.35x | 26.4x | 2.41% | 1.1TCr | ||
| 79.21x | 6.17x | 19.03x | 1.41% | 875.98Cr | ||
| Average | 25.97x | 7.28x | 14.12x | 4.05% | 3.24TCr | |
| Weighted average by Cap. | 22.75x | 7.18x | 13.20x | 3.44% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CG Stock
- Valuation The Carlyle Group Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















